| Financial Year |
March 31 2023 |
| Monetary Funds |
244,200,379.57 |
| Held-for-trading Financial Assets |
350,554,014.78 |
| Notes Receivable |
1,993,114.92 |
| Accounts Receivable |
308,908,559.30 |
| Advances to Suppliers |
8,852,250.79 |
| Other Receivables |
1,498,617.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
285,331,289.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,432,938.47 |
| Total Current Assets |
1,284,787,053.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
319,304,412.05 |
| Under-construction Projects |
119,982,975.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
156,130,766.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,467,190.74 |
| Other Non-Current Assets |
1,186,325.00 |
| Sub-Total of Non-Current Assets |
602,966,950.10 |
| Total Assets |
1,887,754,003.94 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
161,169,706.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,018,160.70 |
| Taxes Payable |
1,384,943.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,252,602.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
731,721.52 |
| Other Current Liabilities |
1,278,264.92 |
| Sub-Total of Current Liabilities |
194,978,747.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,058,336.03 |
| Deferred Income Tax Liabilities |
6,284,374.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,383,948.81 |
| Total Liabilities |
223,362,695.85 |
| Paid-In Capital(Or Share Stock) |
93,600,000.00 |
| Capital Surplus |
1,143,143,793.78 |
| Surplus Reserve |
54,852,070.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
372,855,309.06 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,664,391,308.09 |
| Owner's Equity（Stockholder's Equity） |
1,664,391,308.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,887,754,003.94 |
